Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging
Latest Information Update: 27 Jun 2022
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam
- Indications Sedation
- Focus Adverse reactions
- Acronyms MIDEX MRI
Most Recent Events
- 27 Jun 2022 New trial record